Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Intellectual Property Law (35)
- Entertainment, Arts, and Sports Law (23)
- Health Law and Policy (22)
- Medical Jurisprudence (22)
- International Law (17)
-
- Comparative and Foreign Law (14)
- Constitutional Law (14)
- Torts (14)
- Antitrust and Trade Regulation (13)
- Consumer Protection Law (13)
- Criminal Law (13)
- Criminal Procedure (13)
- Legislation (13)
- Science and Technology Law (13)
- Dispute Resolution and Arbitration (11)
- First Amendment (10)
- Administrative Law (9)
- Jurisdiction (6)
- Law and Gender (5)
- Legal History (5)
- Social Welfare Law (5)
- Banking and Finance Law (4)
- Business (4)
- Environmental Law (4)
- Human Rights Law (4)
- International Trade Law (4)
- Jurisprudence (4)
- Law and Economics (4)
- Keyword
-
- Food and Drug Law (11)
- Torts (7)
- Health Law and Policy (4)
- Criminal Law and Procedure (3)
- Drugs (General) (3)
-
- Drugs (Medicine) (3)
- Social Welfare (3)
- Insurance Law (2)
- Legal Practice and Procedure (2)
- Medical Jurisprudence (2)
- Nonprofit Organizations (2)
- Organizations (2)
- Politics (General) (2)
- Practice of Medicine (2)
- Prescription (2)
- State and Local Government Law (2)
- Strict Liability (2)
- Abortion (1)
- Administrative Law (1)
- Advance Directives (1)
- Birth and Reproduction (1)
- Cause of Action (1)
- Congress (1)
- Controlled Substances (1)
- Domestic Relations (1)
- Drug Abuse (1)
- Duty to Warn (1)
- Economics Law (1)
- Evidence (1)
- Family Responsibility/Support Laws (1)
- Publication Year
- Publication
- Publication Type
Articles 121 - 128 of 128
Full-Text Articles in Food and Drug Law
Deaccession: Not Such A Dirty Word, Jason R. Goldstein
Deaccession: Not Such A Dirty Word, Jason R. Goldstein
Cardozo Arts & Entertainment Law Journal
No abstract provided.
Des Third-Generation Liability: A Proximate Cause, Tracey I. Batt
Des Third-Generation Liability: A Proximate Cause, Tracey I. Batt
Cardozo Law Review
The drug DES has been associated with multigenerational injuries. Although courts in a number of states have allowed many second-generation DES victims to recover from the drug's manufacturers, this remedy, to date, has not been extended to thirdgeneration DES casualties. A number of reasons have been cited for this refusal, but the fear of requiring a drug manufacturer to be perpetually liable to descendants of those who ingested DES as well as the tricky issue of proximate causation predominate. This Note argues that at least some third-generation DES victims could (and should) be allowed to recover, without changing any laws …
To Patent Or Not To Patent: Gene Therapy In The European Union And The United States, Nada Jain
To Patent Or Not To Patent: Gene Therapy In The European Union And The United States, Nada Jain
Cardozo Journal of International and Comparative Law
The note examines the role of patent systems in the biotechnology industry, particularly in gene therapy, comparing the approaches of the EU and the U.S. It highlights how differences in patentability standards, such as the exclusion of treatment methods in the EU versus broader protections in the U.S., impact innovation and investment. The analysis emphasizes the need for balanced patent policies that foster innovation while addressing ethical concerns.
Assembling A Theory Of Infringement: Third Party Liability Based On In Vivo Production Of Patented Pharmaceuticals, Eitan Alexander Ogen
Assembling A Theory Of Infringement: Third Party Liability Based On In Vivo Production Of Patented Pharmaceuticals, Eitan Alexander Ogen
Cardozo Law Review
This Note addresses the novel and still unresolved issues raised by the facts underlying Zenith. Part I describes the patent law system and its importance to the pharmaceutical industry. Part II discusses statutory interpretation issues raised by Zenith, relating to direct infringement and associated third party liability, as they pertain to the metabolic processes of living beings. Part III analyzes these issues in light of the existing case law. Part IV integrates the discussion by proposing a set of factors to be weighed in analyzing infringement actions against third parties that is consistent with the prevailing jurisprudence, the …
Protecting Plant-Derived Drugs: Patents And Beyond, Liz Hanellin
Protecting Plant-Derived Drugs: Patents And Beyond, Liz Hanellin
Cardozo Arts & Entertainment Law Journal
No abstract provided.
Strict Products Liability: The Original Intent, George L. Priest
Strict Products Liability: The Original Intent, George L. Priest
Cardozo Law Review
No abstract provided.
The High Cost Of Free Prescription Drug Samples: An Argument For Federal Regulation, Christine A. Meyers
The High Cost Of Free Prescription Drug Samples: An Argument For Federal Regulation, Christine A. Meyers
Cardozo Law Review
No abstract provided.
The Necessary Complement To Mandatory Immunizations: A National Vaccination Compensation Program, Barbara J. Connolly
The Necessary Complement To Mandatory Immunizations: A National Vaccination Compensation Program, Barbara J. Connolly
Cardozo Law Review
No abstract provided.